Vivos Therapeutics's top three insider shareholders as of September 09, 2026 are Michael C Skaff (TenPercentOwner, 1.35Mn shares), Ronald Kirk Huntsman (Chief Executive Officer, 3.46K shares).
| # | Insider | Position | Direct | Indirect | Total | Share of Insiders | Last Filed |
|---|---|---|---|---|---|---|---|
| 1 | Michael C Skaff | TenPercentOwner | 0 | 1,353,625 | 1,353,625 | 99.7% | 02 Apr, 2026 |
| 2 | Ronald Kirk Huntsman | Chief Executive Officer | 3,461 | 0 | 3,461 | 0.3% | 20 Jun, 2023 |
Each row is that insider’s most recently reported position, from Form 4 filings over the last 60 months — which is why this total does not tie to the quarterly series above, where a quarter counts only the insiders who filed in it. Shares held through a fund or institutional portfolio are counted on the institutional ownership page instead.
| Date | Insider | Position | Transaction | Shares | Price | Value | Shares Held After | Ownership |
|---|---|---|---|---|---|---|---|---|
| 31 Mar, 2026 | Michael C Skaff | TenPercentOwner | Acquired P | 1,044,777 | $1.34 | $1.40Mn | 1,044,777 | Indirect |
| 31 Mar, 2026 | Michael C Skaff | TenPercentOwner | Acquired P | 308,848 | $1.34 | $413.86K | 1,353,625 | Indirect |
| 31 Mar, 2026 | Michael C Skaff | TenPercentOwner | Acquired P | 429,957 | $1.34 | $576.14K | 429,957 | Indirect |
| 31 Mar, 2026 | Michael C Skaff | TenPercentOwner | Acquired P | 1,783,582 | $1.34 | $2.39Mn | 1,783,582 | Indirect |
| 31 Mar, 2026 | Michael C Skaff | TenPercentOwner | Acquired P | 1,783,582 | $1.34 | $2.39Mn | 1,783,582 | Indirect |
| 26 Nov, 2024 | Bradford K. Amman | Chief Financial Officer | Acquired A | 149,533 | $2.64 | $394.77K | 180,533 | Direct |
| 26 Nov, 2024 | Ronald Kirk Huntsman | Chief Executive Officer | Acquired A | 315,421 | $2.64 | $832.71K | 364,755 | Direct |
| 20 Jun, 2024 | Leonard J Sokolow | Director | Acquired A | 4,000 | $2.38 | $9.52K | 7,467 | Direct |
| 20 Jun, 2024 | Anja B Krammer | Director | Acquired A | 4,000 | $2.38 | $9.52K | 7,067 | Direct |
| 20 Jun, 2024 | Ralph Elias Green | Director | Acquired A | 4,000 | $2.38 | $9.52K | 7,067 | Direct |
| 20 Jun, 2024 | Mark F. Lindsay | Director | Acquired A | 4,000 | $2.38 | $9.52K | 7,067 | Direct |
| 20 Jun, 2024 | Matthew Thompson | Director | Acquired A | 4,000 | $2.38 | $9.52K | 7,067 | Direct |
| 20 Jun, 2024 | Bradford K. Amman | Chief Financial Officer | Acquired A | 15,000 | $2.38 | $35.70K | 31,667 | Direct |
| 20 Jun, 2024 | Ronald Kirk Huntsman | Chief Executive Officer | Acquired A | 20,000 | $2.38 | $47.60K | 49,334 | Direct |
| 20 Jun, 2023 | Ronald Kirk Huntsman | Chief Executive Officer | Acquired P | 14,000 | $13.25 | $185.50K | 3,461 | Direct |
| 15 Jun, 2023 | Ronald Kirk Huntsman | Chief Executive Officer | Acquired P | 21 | $12.50 | $263 | 2,301 | Direct |
| 16 Jun, 2023 | Ronald Kirk Huntsman | Chief Executive Officer | Acquired P | 10,000 | $13.50 | $135.00K | 2,701 | Direct |
| 16 Jun, 2023 | Ronald Kirk Huntsman | Chief Executive Officer | Acquired P | 5,000 | $13.25 | $66.25K | 2,901 | Direct |
| 14 Jun, 2023 | Ronald Kirk Huntsman | Chief Executive Officer | Acquired P | 10,000 | $12.25 | $122.50K | 2,300 | Direct |
| 23 Dec, 2022 | Ralph Elias Green | Director | Acquired A | 30,000 | $12.00 | $360.00K | 3,067 | Direct |